Verifying Post-delivery Anal Sphincter Integrity Using Perineal Ultrasound: Impact on Immediate Care
NCT ID: NCT01905644
Last Updated: 2017-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
276 participants
INTERVENTIONAL
2014-03-07
2017-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mediolateral Episiotomy and Obstetric Anal Sphincter Injuries in Instrumental Delivery
NCT04446780
Impedance Spectroscopy in Detection of Obstetric Anal Sphincter Injuries
NCT03769792
Perineal Consequences of Twin Pregnancies According to Mode of Delivery
NCT02059746
In Vivo Evaluation of Perineal Mechanical Properties During Childbirth
NCT05556304
Selective Use of Episiotomy: the Impact on Perineal Trauma.
NCT03559816
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A. Compare the anal incontinence score (measured by the Wexner score, qualitative and quantitative assessment) at 3 months between the two groups.
B. To assess the safety of perineal ultrasound in the group with "ultrasound" using a visual analog scale for discomfort
C. Assess the inter and intra operator consistency of perineal ultrasound snapshot readings
D. Evaluate and compare the rate of infectious complications of perineal sutures between the two groups at 3 months.
E. Evaluate and compare the quality of life (questionnaires PFIQ, PFDI, SF36, Euroqol) between the two groups at 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
With ultrasound
Patients in this group will have perineal ultrasound for the detection of anal sphincter ruptures.
Intervention: Perineal ultrasound
Perineal ultrasound
Perineal ultrasound will be used after delivery to help detect anal sphincter ruptures.
Without ultrasound
Patients in this group will not have perineal ultrasound for the detection of anal sphincter ruptures.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Perineal ultrasound
Perineal ultrasound will be used after delivery to help detect anal sphincter ruptures.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be insured or beneficiary of a health insurance plan
* The patient is available for 3 months of follow-up
* Paturient, vaginal births only
* Presence of \>= stage 2 perineal lesion
* Patient accepts a priori the performance of a perineal ultrasound
Exclusion Criteria
* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient refuses to sign the consent
* It is impossible to correctly inform the patient
* Delivery by C-section
* Intact perineum after delivery (no indication for perineal surgery in light of absence of vaginal lesion)
* Emergency situation preventing time for perineal ultrasound
* History of anal incontinence before giving birth
* Allergy to ultrasound gel
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vincent Letouzey, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, , France
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
CHU de Poitiers
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A00773-42
Identifier Type: OTHER
Identifier Source: secondary_id
AOI/2012/VL-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.